Home
Products
CLIA
Analyzers
Reagents
Chemistry
TLA
LIA
ESR
Pubilcations
Autoimmunity
Reproductive Health
Diabetes
Liver Disease
Infection
COVID-19
Others
News
YHLO News
About YHLO
Company Profile
Milestone
Corporate Values
Contact us
Career
Service
2024/06/05
Identification and characterization of novel compound heterozygous variants in FSHR causing primary ovarian insufficiency with resistant ovary syndrome
Protein palmitoylation-mediated palmitic acid sensing causes blood-testis barrier damage via inducing ER stress
Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVFICSI fresh cycle
Semen parameters in men recovered from COVID-19
Clinical Application Value of Inhibin B alone or in combination with other hormone indicators in Subfertile Men with Different Spermatogenesis Status A Study o
Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment
A visualized clinical model predicting good quality blastocyst development in the first IVFICSI cycle
Performance evaluation of a fully automated anti-Mu¨ llerian hormone immunoassay and multicentre study on the establishment of reference range in adult women
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early
Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
Tel: +86 755 26601910
Email: marketing@szyhlo.com
Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.
Powered by 300.cn | SEO | Business License
Email
8
marketing@szyhlo.com
Tel
9
+86 755 26601910